|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 AED | +0.92% |
|
+5.77% | -5.98% |
| Jun. 08 | UAE Stocks Slide on Renewed Iran-Israel Attacks; OPEC+ Boosts July Oil Output | MT |
| Jun. 08 | Julphar Finalizes Sale of Pharmacy Chain in UAE; Oman Divestment Pending Government Clearance | MT |
| Market Cap | 1.27B 346M 298M 275M 258M 484M 32.71B 489M 3.24B 1.26B 16.02B 1.3B 55.51B | P/E Ratio 2026 * |
-
| P/E Ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.02B 278M 239M 221M 207M 389M 26.27B 393M 2.61B 1.02B 12.87B 1.04B 44.59B | EV / Sales 2026 * |
0.9x | EV / Sales 2027 * | 0.8x |
| Free-Float |
34.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.92% | ||
| 1 week | +5.77% | ||
| Current month | +1.85% | ||
| 1 month | +1.85% | ||
| 3 months | +4.76% | ||
| 6 months | -9.84% | ||
| Current year | -5.98% |
| 1 week | 1.05 |  | 1.13 |
| 1 month | 1.01 | | 1.13 |
| Current year | 0.96 | | 1.26 |
| 1 year | 0.96 | | 1.61 |
| 3 years | 0.7 | | 1.78 |
| 5 years | 0.7 | | 2.32 |
| 10 years | 0.7 | | 4.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Basel Ziyadeh
CEO | Chief Executive Officer | - | - |
Khalid Malkawi
DFI | Director of Finance/CFO | - | - |
Malik Metahri
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2016-12-31 | |
| Director/Board Member | - | 2018-12-31 | |
| Chairman | - | 2004-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +5.77% | -12.70% | +35.80% | 343M | |
| +0.23% | -3.70% | +42.26% | +5.35% | 284B | |
| -0.49% | -3.93% | +15.03% | -19.58% | 66.94B | |
| -2.30% | -2.57% | +29.15% | +99.09% | 8.45B | |
| +0.54% | +1.65% | -3.53% | -11.14% | 7.81B | |
| -1.66% | +7.65% | -1.77% | +11.15% | 4.67B | |
| -0.76% | +8.15% | -26.48% | +39.35% | 3.89B | |
| -5.27% | +3.33% | -20.20% | +4.08% | 3.32B | |
| -0.64% | -4.56% | +34.22% | +29.05% | 2.55B | |
| -2.22% | +3.56% | +4.29% | -22.89% | 1.99B | |
| Average | -1.20% | +0.23% | +6.03% | +17.03% | 38.37B | |
| Weighted average by Cap. | -0.09% | -3.37% | +34.21% | +3.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.13B 308M 266M 245M 230M 431M 29.14B 436M 2.89B 1.13B 14.27B 1.16B 49.45B | 1.22B 332M 286M 264M 248M 465M 31.43B 470M 3.12B 1.21B 15.39B 1.25B 53.34B |
| Net income | - | - |
| Net Debt | -250M -68.06M -58.65M -54.01M -50.71M -95.21M -6.43B -96.22M -638M -249M -3.15B -255M -10.92B | -294M -80.04M -68.98M -63.52M -59.64M -112M -7.57B -113M -751M -292M -3.71B -300M -12.84B |
Employees
2,400
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 1.100 AED | +0.92% | 2,439,536 |
| 26-06-12 | 1.090 AED | +2.83% | 5,875,352 |
| 26-06-11 | 1.060 AED | +0.95% | 361,861 |
| 26-06-10 | 1.050 AED | -1.87% | 216,596 |
| 26-06-09 | 1.070 AED | +2.88% | 887,316 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.100AED
Average target price
1.560AED
Spread / Average Target
+41.82%
Net sales - Rate of surprise
- Stock Market
- Stocks
- JULPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
